Resources

All resources

Access a curated library of reports, policy submissions, data insights, and other materials informing Canada’s life sciences ecosystem.

Filter by

October 13, 2026

Canadians continue to wait two years for access to new medicines: New data report

New medicines aren’t always available through public drug plans when Canadian patients need them. After Health Canada approves a new medicine as safe and effective, Canadians still wait an average of two years for access. These delays have existed for many years, yet little progress was made in 2025, with the notable exception of the Ontario government’s Funding Accelerated for Specific Treatments (FAST) Program.

Learn more | View

Access to medicine

February 06, 2026

Pre-budget submission 2026

Innovative Medicines Canada (IMC) is pleased to contribute to the Quebec government’s consultations on its 2026-27 budget. Availability of and […]

Learn more | View

Access to medicine
1 2 3

resources

Discover. Learn.
Understand.

Stay informed with timely, relevant content on key issues shaping our industry.

Learn more